Arena Pharma (ARNA) BELVIQ Trends Remain Underwhelming, BMO Capital Notes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- Atlassian results seen as 'game changer' for AI kills software worries
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Arena Pharma (ARNA), Eisai Will Present Lorcaserin HCl Data at Two Upcoming Meetings
May 14, 2015 8:02 AM EDTEisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that lorcaserin HCl data will be presented at the following medical meetings:
American Thoracic Society International Conference taking place in Denver, Colorado, May 15-20, 2015Lorcaserin for Smoking Cessation Treatment in Cigarette Smokers:... MoreArena Pharma (ARNA) Tops Q1 EPS by 4c
May 11, 2015 4:09 PM EDTArena Pharma (NASDAQ: ARNA) reported Q1 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.56 million.
At March 31, 2015, cash and cash equivalents totaled $241.0 million, including net proceeds of $100.7 million from... More
